What type of study is this?

This is a Animal Study study (also classified as: In Vitro Study, Experimental Study).

September 27, 2025Microbiology SpectrumOpen Access

Advancing antifungal therapy: exploring targeted CFW-PEc-enhanced ethosomal formulations of amphotericin B against cryptococcal pneumonia

View Full Paper

Ask AI

Bookmark

Authors

Innovative antifungal approach improves efficacy and reduces cytotoxicity in cryptococcal pneumonia, indicating new treatment possibilities.

CFW-PEc-AmB-ethosomes drastically reduce fungal burden in a mouse model of cryptococcal pneumonia.
This formulation shows a remarkable 10-fold improvement in antifungal efficacy compared to conventional treatments.
In vitro studies indicate reduced cytotoxicity while maintaining high drug entrapment efficiency.
The targeting mechanism of CFW-PEc enhances drug delivery and minimizes side effects, paving the way for improved therapies.

Shi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Innovative antifungal approach improves efficacy and reduces cytotoxicity in cryptococcal pneumonia, indicating new treatment possibilities.